The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Neutropenic Fever (Febrile Neutropenia)

Oncologic emergency in chemotherapy patients with low neutrophil counts and fever.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Neutropenic Fever (Febrile Neutropenia)?

Neutropenic fever, also called febrile neutropenia (FN), is defined as a single oral temperature of 38.3°C or higher, or a sustained temperature of 38°C or higher for at least 1 hour, in a patient with absolute neutrophil count below 0.5 x 10^9/L or expected to fall below this threshold within 48 hours. It typically follows myelosuppressive chemotherapy and is one of the most common oncologic emergencies.

Without functioning neutrophils, the typical inflammatory response to infection is muted, allowing rapid progression to bacteremia, sepsis, and septic shock. The most common pathogens are gram-negative bacilli (E. coli, Klebsiella, Pseudomonas) and gram-positive cocci (coagulase-negative staphylococci from central lines, Streptococcus, MRSA). Fungal infections become important after prolonged neutropenia (more than 7 days) or persistent fever.

Outcomes depend on time-to-antibiotic, with door-to-needle goal under 60 minutes. Risk stratification using MASCC or CISNE scores guides outpatient versus inpatient management. Risk-adapted empiric regimens, source identification, and de-escalation upon culture results form the core of management. Prophylactic G-CSF and antimicrobial prophylaxis reduce future episodes.

Symptoms

Single fever 38.3°C or higher
Sustained 38°C or higher for over 1 hour
Chills, rigors, malaise
Tachycardia, tachypnea
Hypotension or shock signs
Mucositis, ulcers
Catheter site redness, pain, drainage
Cough, dyspnea (pneumonia)
Abdominal pain, diarrhea (typhlitis)
Dysuria, perineal pain
Skin lesions (ecthyma gangrenosum from Pseudomonas)
Confusion or altered mentation
Lethargy, weakness
Reduced urine output

Risk Factors

Hematologic malignancy (acute leukemia, lymphoma)
Allogeneic or autologous stem cell transplant
High-dose myelosuppressive chemotherapy
Prolonged neutropenia (more than 7 days)
Mucositis breakdown
Indwelling central venous catheter
Older age
Comorbidities (diabetes, COPD, heart failure)
Prior multidrug-resistant colonization
Hospital-acquired exposure
Suboptimal G-CSF prophylaxis

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Any fever 38.3°C or higher in chemotherapy patient
  • Sustained 38°C for over 1 hour
  • Chills, weakness, dizziness, confusion
  • Catheter pain, redness, drainage
  • Severe mucositis with inability to swallow
  • Severe abdominal pain, vomiting, diarrhea
  • Difficulty breathing or chest pain
  • Hypotension, fainting, sepsis signs

Treatment Methods

01
Immediate triage: vitals, focused exam, neutrophil count, lactate
02
Blood cultures (peripheral and from each lumen of central catheter)
03
Urine, sputum, wound, CSF cultures as indicated
04
Empiric IV antibiotics within 1 hour after cultures
05
Standard first-line: cefepime, piperacillin-tazobactam, or meropenem (single agent)
06
Vancomycin added for: hemodynamic instability, severe mucositis, suspected catheter infection, MRSA risk, prior gram-positive bacteremia
07
Aminoglycoside added for septic shock or suspected resistant gram-negative
08
Aztreonam plus vancomycin for severe penicillin allergy
09
Antifungal therapy after 4-7 days persistent fever (caspofungin, voriconazole, lipid amphotericin B based on epidemiology)
10
MASCC or CISNE risk score: low-risk patients may receive oral ciprofloxacin plus amoxicillin-clavulanate as outpatient
11
Imaging: chest CT for pulmonary symptoms, CT abdomen for typhlitis or intra-abdominal source
12
Source control: catheter removal in tunnel infection, abscess drainage
13
Supportive care: IV fluids, vasopressors, electrolyte and glucose management
14
Reassess clinical status and culture data daily; adjust antibiotics
15
De-escalate to narrowest appropriate spectrum after pathogen identification
16
Discontinue antibiotics 5-7 days after defervescence and ANC recovery if no documented infection
17
Avoid digital rectal exam to prevent translocation
18
Hand hygiene and protective isolation
19
Future cycle prophylaxis: G-CSF (filgrastim, pegfilgrastim), fluoroquinolone, antifungal/antiviral as indicated
20
Patient education on early recognition, thermometer use, prompt presentation
21
Multidisciplinary care: oncology, infectious diseases, pharmacy, nursing

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.